SEVOFLURANE 99.97 %
SEVOFLURANE : 99.97 % · DIN 02265974 · BAXTER CORPORATION
Health Canada status: MARKETED
What is SEVOFLURANE?
SEVOFLURANE 99.97 % contains SEVOFLURANE : 99.97 %. It is listed in the Health Canada Drug Product Database under DIN 02265974, held by BAXTER CORPORATION, supplied as LIQUID for INHALATION administration. Health Canada currently lists it as marketed, status dated 11-Apr-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SEVOFLURANE used for?
SEVOFLURANE (sevoflurane) is indicated for: • induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02265974 |
|---|---|
| Brand name | SEVOFLURANE |
| Generic / active ingredient | SEVOFLURANE : 99.97 % |
| Manufacturer | BAXTER CORPORATION |
| Strength | 99.97 % |
| Dosage form | LIQUID |
| Route of administration | INHALATION |
| Schedule | Prescription |
| ATC code | N01AB08 SEVOFLURANE |
| AHFS class | 28:04.16 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 11-Apr-2007 |
| Original market date | 2007-04-11 00:00:00 |
How is it stored and handled?
null
How is it supplied?
250 mL aluminum bottle
What can be used instead?
Other Canadian products sharing ATC code N01AB08 SEVOFLURANE. 3 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SEVOFLURANE | 99.97 % | LIQUID | PIRAMAL CRITICAL CARE INC | MARKETED | DIN 02307766 |
| SEVORANE AF | 99.97 % | LIQUID | ABBVIE CORPORATION | MARKETED | DIN 02172763 |
| SEVOFLURANE | 99.9875 % | LIQUID | BLUE-ZONE TECHNOLOGIES LTD | APPROVED | DIN 02553449 |
Who else supplies SEVOFLURANE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SEVOFLURANE appears in 687 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.